Anti-inflammatory signaling in microglia exacerbates Alzheimer's disease-related pathology

Jean-Philippe Michaud1, Serge Rivest1

  • 1Neuroscience Laboratory, CHU de Québec Research Center, Department of Molecular Medicine, Faculty of medicine, Laval University, 2705 Laurier Boulevard, QC G1V 4G2, Canada.

Neuron
|February 6, 2015
PubMed

Insights

The anti-inflammatory cytokine IL-10 hinders amyloid-beta (Aβ) clearance by microglia, exacerbating cognitive decline in Alzheimer's disease mouse models. This suggests pro-inflammatory signaling acts as a defense against Alzheimer's disease progression.

Area of Science:

  • Neuroscience
  • Immunology
  • Alzheimer's Disease Research

Background:

  • Alzheimer's disease (AD) is characterized by amyloid-beta (Aβ) plaques.
  • Microglia play a crucial role in clearing Aβ.
  • The role of inflammation in AD pathogenesis is complex and debated.

Purpose of the Study:

  • To investigate the effect of the anti-inflammatory cytokine IL-10 on Aβ clearance by microglia.
  • To determine the impact of IL-10 on cognitive function in mouse models of AD.
  • To elucidate the role of pro-inflammatory signaling in AD innate immune defense.

Main Methods:

  • Utilized mouse models of Alzheimer's disease.
  • Assessed the impact of IL-10 on microglial Aβ clearance.
  • Evaluated cognitive decline in response to IL-10 modulation.

Main Results:

  • The anti-inflammatory cytokine IL-10 was found to inhibit Aβ clearance by microglia.
  • Administration of IL-10 worsened cognitive decline in AD mouse models.
  • These findings indicate that IL-10 negatively affects AD pathology.

Conclusions:

  • IL-10 impairs microglial Aβ clearance, contributing to cognitive deficits in AD.
  • Pro-inflammatory signaling appears to be an innate immune defense mechanism in Alzheimer's disease.
  • Targeting IL-10 may offer a therapeutic strategy for enhancing Aβ clearance in AD.

Related Concept Videos

Alzheimer Disease ll: Pathophysiology01:23

Alzheimer Disease ll: Pathophysiology

Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and...
1
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
2
Chronic Inflammation: Introduction01:12

Chronic Inflammation: Introduction

Chronic inflammation is a prolonged, dysregulated immune response that persists for weeks to years when the inciting stimulus is difficult to eradicate or when self‑antigens drive ongoing reactivity. Morphologically, it is defined by mononuclear cell infiltration, progressive tissue destruction, and concurrent attempts at healing via angiogenesis and fibrosis. Compared with acute inflammation, edema is less prominent while cellular infiltration predominates; triggers include persistent...
4